Astragaloside IV Attenuates Acetaminophen-Induced Liver Injuries in Mice by Activating the Nrf2 Signaling Pathway.
Astragaloside IV Attenuates Acetaminophen-Induced Liver Injuries in Mice by Activating the Nrf2 Signaling Pathway.
复制标题
星形镜IV通过激活NRF2信号途径来减轻小鼠乙酰氨基酚诱导的肝损伤。
DOI:
10.3390/molecules23082032
复制
发表时间:
2018-08-14
期刊:
影响因子:
--
通讯作者:
Liu C
中科院分区:
文献类型:
--
作者:
Li L;Huang W;Wang S;Sun K;Zhang W;Ding Y;Zhang L;Tumen B;Ji L;Liu C
Acetaminophen (APAP) is a well-known antipyretic and analgesic drug. However, the accidental or intentional APAP overdose will induce liver injury and even acute liver failure. Astragaloside IV (AS-IV), a bioactive compound isolated from Astragali Radix, has been reported to have protective effects on the digestive and immune systems because of its anti-oxidant and anti-inflammatory properties. This study aims to observe whether AS-IV pretreatment provides protection against APAP-induced liver failure. The results of serum alanine/aspartate aminotransferases (ALT/AST) analysis, hepatic glutathione (GSH), and malondialdehyde (MDA) amounts, and liver superoxide dismutase (SOD) activity showed that AS-IV protected against APAP-induced hepatotoxicity. Liver histological observation further evidenced this protection provided by AS-IV. AS-IV was found to reverse the APAP-induced increased amounts of pro-inflammatory cytokines, including interleukin 1β (IL-1β), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α). Western-blot analysis showed that AS-IV increased the transcriptional activation of nuclear factor erythroid 2-related factor 2 (Nrf2), and enhanced the expression of heme oxygenase 1 (HO-1) and reduced nicotinamide adenine dinucleotide phosphate (NAD(P)H): quinone oxidoreductase 1 (NQO1) in the presence of APAP. AS-IV also decreased the expression of kelch-like ECH-associated protein-1 (Keap1). In conclusion, we demonstrated that AS-IV exerted a strong protection against APAP-induced hepatotoxicity by activating Nrf2 antioxidant signaling pathways.
登录
查看更多内容
影响因子:
4.6
作者:
Zhang WJ;Frei B
通讯作者:
Frei B
影响因子:
--
作者:
Pan CW;Yang SX;Pan ZZ;Zheng B;Wang JZ;Lu GR;Xue ZX;Xu CL
通讯作者:
Xu CL
影响因子:
2.4
作者:
Balaban YH;Aka C;Koca-Caliskan U
通讯作者:
Koca-Caliskan U
影响因子:
5.6
作者:
Yang, Changming;Yi, Jun;Zhang, Li
通讯作者:
Zhang, Li
影响因子:
5.1
作者:
Bunchorntavakul, Chalermrat;Reddy, K. Rajender
通讯作者:
Reddy, K. Rajender